Member Exclusive

Cell therapy weekly: Fujifilm to pump JP¥10 billion into contract manufacturing

This week: DiscGenics spinal cord therapy passes first-in-human safety review and research uncovers why checkpoint blockade therapies succeed or fail.

Go to the profile of RegMedNet
Jan 10, 2019
0
0

Please sign in or register for FREE

No comments yet.